How GeneDX CEO Katherine Stueland is using AI to save lives
Share

How GeneDX CEO Katherine Stueland is using AI to save lives

She started her career helping launch breakthrough treatments for HIV and cancer. Today, Katherine Stueland is leading GeneDx — a genetic testing company using genomic insights to diagnose rare diseases faster and more accurately than ever before.
28:41
Tue, Oct 14 202510:15 AM EDT

The "CNBC Changemakers and Power Players" podcast delivers candid, in-depth interviews with trailblazing women in business. In this episode, CNBC's Julia Boorstin sits down with Katherine Stueland, CEO of GeneDX — one of the fastest-growing genomics companies in the U.S.

In this episode, Stueland talks about how she helped turn GeneDx around — taking the company from challenge to profitability while changing the way rare diseases are diagnosed and treated. She opens up about finding confidence later in her career, why showing vulnerability makes her a stronger leader, and how she's bringing purpose and humanity to the world of biotech.

Follow and listen to the "CNBC Changemakers and Power Players" podcast on Apple and Spotify.